 | • レポートコード：MRC2-11QY04913 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は1型糖尿病のグローバル市場について調査・分析したレポートです。種類別（速効性、長時間作用性、プレミックス）市場規模、用途別（病院、診断クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別1型糖尿病の競争状況、市場シェア ・世界の1型糖尿病市場：種類別市場規模 2015年-2020年（速効性、長時間作用性、プレミックス） ・世界の1型糖尿病市場：種類別市場規模予測 2021年-2026年（速効性、長時間作用性、プレミックス） ・世界の1型糖尿病市場：用途別市場規模 2015年-2020年（病院、診断クリニック） ・世界の1型糖尿病市場：用途別市場規模予測 2021年-2026年（病院、診断クリニック） ・北米の1型糖尿病市場分析：米国、カナダ ・ヨーロッパの1型糖尿病市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの1型糖尿病市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の1型糖尿病市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの1型糖尿病市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Bayer、Eli Lilly、BD、Johnson & Johnson、Merck、Pfizer、AstraZeneca、Roche、Smiths Medical、Medtronic ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Type 1 diabetes is a form of diabetes mellitus in which very little or no insulin is produced by the pancreas.
The global type 1 diabetes market is expected to grow modestly during the forecast period owing to growing incidence and prevalence of diabetes and cohesive government policies.
Market Analysis and Insights: Global Type 1 Diabetes Market
The global Type 1 Diabetes market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Type 1 Diabetes Scope and Market Size
Type 1 Diabetes market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Type 1 Diabetes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Bayer
Eli Lilly
BD
Johnson & Johnson
Merck
Pfizer
AstraZeneca
Roche
Smiths Medical
Medtronic
Market segment by Type, the product can be split into
Rapid-acting
Long-acting
Premix
Market segment by Application, split into
Hospitals
Diagnostic clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Type 1 Diabetes Revenue
1.4 Market by Type
1.4.1 Global Type 1 Diabetes Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Rapid-acting
1.4.3 Long-acting
1.4.4 Premix
1.5 Market by Application
1.5.1 Global Type 1 Diabetes Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Type 1 Diabetes Market Perspective (2015-2026)
2.2 Global Type 1 Diabetes Growth Trends by Regions
2.2.1 Type 1 Diabetes Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Type 1 Diabetes Historic Market Share by Regions (2015-2020)
2.2.3 Type 1 Diabetes Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Type 1 Diabetes Market Growth Strategy
2.3.6 Primary Interviews with Key Type 1 Diabetes Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Type 1 Diabetes Players by Market Size
3.1.1 Global Top Type 1 Diabetes Players by Revenue (2015-2020)
3.1.2 Global Type 1 Diabetes Revenue Market Share by Players (2015-2020)
3.1.3 Global Type 1 Diabetes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Type 1 Diabetes Market Concentration Ratio
3.2.1 Global Type 1 Diabetes Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Type 1 Diabetes Revenue in 2019
3.3 Type 1 Diabetes Key Players Head office and Area Served
3.4 Key Players Type 1 Diabetes Product Solution and Service
3.5 Date of Enter into Type 1 Diabetes Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Type 1 Diabetes Historic Market Size by Type (2015-2020)
4.2 Global Type 1 Diabetes Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Type 1 Diabetes Market Size by Application (2015-2020)
5.2 Global Type 1 Diabetes Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Type 1 Diabetes Market Size (2015-2020)
6.2 Type 1 Diabetes Key Players in North America (2019-2020)
6.3 North America Type 1 Diabetes Market Size by Type (2015-2020)
6.4 North America Type 1 Diabetes Market Size by Application (2015-2020)
7 Europe
7.1 Europe Type 1 Diabetes Market Size (2015-2020)
7.2 Type 1 Diabetes Key Players in Europe (2019-2020)
7.3 Europe Type 1 Diabetes Market Size by Type (2015-2020)
7.4 Europe Type 1 Diabetes Market Size by Application (2015-2020)
8 China
8.1 China Type 1 Diabetes Market Size (2015-2020)
8.2 Type 1 Diabetes Key Players in China (2019-2020)
8.3 China Type 1 Diabetes Market Size by Type (2015-2020)
8.4 China Type 1 Diabetes Market Size by Application (2015-2020)
9 Japan
9.1 Japan Type 1 Diabetes Market Size (2015-2020)
9.2 Type 1 Diabetes Key Players in Japan (2019-2020)
9.3 Japan Type 1 Diabetes Market Size by Type (2015-2020)
9.4 Japan Type 1 Diabetes Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Type 1 Diabetes Market Size (2015-2020)
10.2 Type 1 Diabetes Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Type 1 Diabetes Market Size by Type (2015-2020)
10.4 Southeast Asia Type 1 Diabetes Market Size by Application (2015-2020)
11 India
11.1 India Type 1 Diabetes Market Size (2015-2020)
11.2 Type 1 Diabetes Key Players in India (2019-2020)
11.3 India Type 1 Diabetes Market Size by Type (2015-2020)
11.4 India Type 1 Diabetes Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Type 1 Diabetes Market Size (2015-2020)
12.2 Type 1 Diabetes Key Players in Central & South America (2019-2020)
12.3 Central & South America Type 1 Diabetes Market Size by Type (2015-2020)
12.4 Central & South America Type 1 Diabetes Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Type 1 Diabetes Introduction
13.1.4 Abbott Revenue in Type 1 Diabetes Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Type 1 Diabetes Introduction
13.2.4 Bayer Revenue in Type 1 Diabetes Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Type 1 Diabetes Introduction
13.3.4 Eli Lilly Revenue in Type 1 Diabetes Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 BD
13.4.1 BD Company Details
13.4.2 BD Business Overview
13.4.3 BD Type 1 Diabetes Introduction
13.4.4 BD Revenue in Type 1 Diabetes Business (2015-2020)
13.4.5 BD Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Type 1 Diabetes Introduction
13.5.4 Johnson & Johnson Revenue in Type 1 Diabetes Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Type 1 Diabetes Introduction
13.6.4 Merck Revenue in Type 1 Diabetes Business (2015-2020)
13.6.5 Merck Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Type 1 Diabetes Introduction
13.7.4 Pfizer Revenue in Type 1 Diabetes Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview
13.8.3 AstraZeneca Type 1 Diabetes Introduction
13.8.4 AstraZeneca Revenue in Type 1 Diabetes Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Roche
13.9.1 Roche Company Details
13.9.2 Roche Business Overview
13.9.3 Roche Type 1 Diabetes Introduction
13.9.4 Roche Revenue in Type 1 Diabetes Business (2015-2020)
13.9.5 Roche Recent Development
13.10 Smiths Medical
13.10.1 Smiths Medical Company Details
13.10.2 Smiths Medical Business Overview
13.10.3 Smiths Medical Type 1 Diabetes Introduction
13.10.4 Smiths Medical Revenue in Type 1 Diabetes Business (2015-2020)
13.10.5 Smiths Medical Recent Development
13.11 Medtronic
10.11.1 Medtronic Company Details
10.11.2 Medtronic Business Overview
10.11.3 Medtronic Type 1 Diabetes Introduction
10.11.4 Medtronic Revenue in Type 1 Diabetes Business (2015-2020)
10.11.5 Medtronic Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Type 1 Diabetes Key Market Segments
Table 2. Key Players Covered: Ranking by Type 1 Diabetes Revenue
Table 3. Ranking of Global Top Type 1 Diabetes Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Type 1 Diabetes Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Rapid-acting
Table 6. Key Players of Long-acting
Table 7. Key Players of Premix
Table 8. Global Type 1 Diabetes Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Type 1 Diabetes Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Type 1 Diabetes Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Type 1 Diabetes Market Share by Regions (2015-2020)
Table 12. Global Type 1 Diabetes Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Type 1 Diabetes Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Type 1 Diabetes Market Growth Strategy
Table 18. Main Points Interviewed from Key Type 1 Diabetes Players
Table 19. Global Type 1 Diabetes Revenue by Players (2015-2020) (Million US$)
Table 20. Global Type 1 Diabetes Market Share by Players (2015-2020)
Table 21. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 1 Diabetes as of 2019)
Table 22. Global Type 1 Diabetes by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Type 1 Diabetes Product Solution and Service
Table 25. Date of Enter into Type 1 Diabetes Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Type 1 Diabetes Market Size by Type (2015-2020) (Million US$)
Table 28. Global Type 1 Diabetes Market Size Share by Type (2015-2020)
Table 29. Global Type 1 Diabetes Revenue Market Share by Type (2021-2026)
Table 30. Global Type 1 Diabetes Market Size Share by Application (2015-2020)
Table 31. Global Type 1 Diabetes Market Size by Application (2015-2020) (Million US$)
Table 32. Global Type 1 Diabetes Market Size Share by Application (2021-2026)
Table 33. North America Key Players Type 1 Diabetes Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Type 1 Diabetes Market Share (2019-2020)
Table 35. North America Type 1 Diabetes Market Size by Type (2015-2020) (Million US$)
Table 36. North America Type 1 Diabetes Market Share by Type (2015-2020)
Table 37. North America Type 1 Diabetes Market Size by Application (2015-2020) (Million US$)
Table 38. North America Type 1 Diabetes Market Share by Application (2015-2020)
Table 39. Europe Key Players Type 1 Diabetes Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Type 1 Diabetes Market Share (2019-2020)
Table 41. Europe Type 1 Diabetes Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Type 1 Diabetes Market Share by Type (2015-2020)
Table 43. Europe Type 1 Diabetes Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Type 1 Diabetes Market Share by Application (2015-2020)
Table 45. China Key Players Type 1 Diabetes Revenue (2019-2020) (Million US$)
Table 46. China Key Players Type 1 Diabetes Market Share (2019-2020)
Table 47. China Type 1 Diabetes Market Size by Type (2015-2020) (Million US$)
Table 48. China Type 1 Diabetes Market Share by Type (2015-2020)
Table 49. China Type 1 Diabetes Market Size by Application (2015-2020) (Million US$)
Table 50. China Type 1 Diabetes Market Share by Application (2015-2020)
Table 51. Japan Key Players Type 1 Diabetes Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Type 1 Diabetes Market Share (2019-2020)
Table 53. Japan Type 1 Diabetes Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Type 1 Diabetes Market Share by Type (2015-2020)
Table 55. Japan Type 1 Diabetes Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Type 1 Diabetes Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Type 1 Diabetes Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Type 1 Diabetes Market Share (2019-2020)
Table 59. Southeast Asia Type 1 Diabetes Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Type 1 Diabetes Market Share by Type (2015-2020)
Table 61. Southeast Asia Type 1 Diabetes Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Type 1 Diabetes Market Share by Application (2015-2020)
Table 63. India Key Players Type 1 Diabetes Revenue (2019-2020) (Million US$)
Table 64. India Key Players Type 1 Diabetes Market Share (2019-2020)
Table 65. India Type 1 Diabetes Market Size by Type (2015-2020) (Million US$)
Table 66. India Type 1 Diabetes Market Share by Type (2015-2020)
Table 67. India Type 1 Diabetes Market Size by Application (2015-2020) (Million US$)
Table 68. India Type 1 Diabetes Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Type 1 Diabetes Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Type 1 Diabetes Market Share (2019-2020)
Table 71. Central & South America Type 1 Diabetes Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Type 1 Diabetes Market Share by Type (2015-2020)
Table 73. Central & South America Type 1 Diabetes Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Type 1 Diabetes Market Share by Application (2015-2020)
Table 75. Abbott Company Details
Table 76. Abbott Business Overview
Table 77. Abbott Product
Table 78. Abbott Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 79. Abbott Recent Development
Table 80. Bayer Company Details
Table 81. Bayer Business Overview
Table 82. Bayer Product
Table 83. Bayer Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 84. Bayer Recent Development
Table 85. Eli Lilly Company Details
Table 86. Eli Lilly Business Overview
Table 87. Eli Lilly Product
Table 88. Eli Lilly Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 89. Eli Lilly Recent Development
Table 90. BD Company Details
Table 91. BD Business Overview
Table 92. BD Product
Table 93. BD Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 94. BD Recent Development
Table 95. Johnson & Johnson Company Details
Table 96. Johnson & Johnson Business Overview
Table 97. Johnson & Johnson Product
Table 98. Johnson & Johnson Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 99. Johnson & Johnson Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Product
Table 103. Merck Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 104. Merck Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Product
Table 108. Pfizer Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 109. Pfizer Recent Development
Table 110. AstraZeneca Business Overview
Table 111. AstraZeneca Product
Table 112. AstraZeneca Company Details
Table 113. AstraZeneca Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 114. AstraZeneca Recent Development
Table 115. Roche Company Details
Table 116. Roche Business Overview
Table 117. Roche Product
Table 118. Roche Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 119. Roche Recent Development
Table 120. Smiths Medical Company Details
Table 121. Smiths Medical Business Overview
Table 122. Smiths Medical Product
Table 123. Smiths Medical Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 124. Smiths Medical Recent Development
Table 125. Medtronic Company Details
Table 126. Medtronic Business Overview
Table 127. Medtronic Product
Table 128. Medtronic Revenue in Type 1 Diabetes Business (2015-2020) (Million US$)
Table 129. Medtronic Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Type 1 Diabetes Market Share by Type: 2020 VS 2026
Figure 2. Rapid-acting Features
Figure 3. Long-acting Features
Figure 4. Premix Features
Figure 5. Global Type 1 Diabetes Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Diagnostic clinics Case Studies
Figure 8. Type 1 Diabetes Report Years Considered
Figure 9. Global Type 1 Diabetes Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Type 1 Diabetes Market Share by Regions: 2020 VS 2026
Figure 11. Global Type 1 Diabetes Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Type 1 Diabetes Market Share by Players in 2019
Figure 14. Global Top Type 1 Diabetes Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Type 1 Diabetes as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Type 1 Diabetes Revenue in 2019
Figure 16. North America Type 1 Diabetes Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Type 1 Diabetes Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Type 1 Diabetes Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Type 1 Diabetes Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Type 1 Diabetes Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Type 1 Diabetes Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Type 1 Diabetes Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
無針糖尿病治療の世界市場（～2026年） Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic con…- 糖尿病・関連疾患用幹細胞療法の世界市場（～2026年） Diabetes is the metabolic disorder that is associated with the glucose level in the blood. It is mainly divided into two types, insulin-dependent diabetes mellitus or juvenile onset (type 1) and non-insulin-dependent diabetes mellitus, or adult-onset diabetes (type 2). NSI-566 is the stem cell thera…
- 次世代糖尿病治療・ドラッグデリバリーの世界市場（～2026年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …
- 糖尿病検査室イムノアッセイの世界市場（～2026年） Market Analysis and Insights: Global Diabetes Laboratory Immunoassays Market The global Diabetes Laboratory Immunoassays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Diabetes Laboratory Immunoassays Scope and Market…
- 糖尿病用非インスリン療法の世界市場（～2026年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 32930 million by 2026, from US$ 30040 million in 2020, at a CAGR of 8.9%% during 2021-2026. Global Non-Insulin Therapies for Diabetes Sco…